# Novo drug trial fail deals setback to bid to expand beyond obesity

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-01 07:29 UTC · Category: Business · Sources: 1 · Current Velocity: 0.25

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| GlobeNewswire | Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation | 2026-07-31 21:20 | [Source Link](https://news.google.com/rss/articles/CBMi_AFBVV95cUxNakVJNDVDSWgwS19wcEs1WXZqeldPRlRVOTNqY3FPMlU0OWl0cG5QZ3BTOEJYc3cyWXBNVWhLWkVjRS1IYkhtcHJxMnlHWVE2cy0xYTVLWEdTNERHTHlnQzFqR0M5VzRfQVZ1TTlNdVMxVFZFcVd6M2MyT19sWTlqRHpiQTFoTk50TlNUcjRfY2RSVGJMeDg1TFhjSkM2MnN0bC1qeTFZdnI1cVZ2NEs5al8yVndUT1NaeWpwZTdMeFFVb1g5SER0OTBReWRwRU1UWWVtbHptdUtDbG5sOEVmU2tWaEdqWWhqekkwTUprVXVWTmg3UUhfV1dnbWw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-01/novo-drug-trial-fail-deals-setback-to-bid-to-expand-beyond-obesity*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*